Who owns Nektar Therapeutics?

Key details on Nektar Therapeutics (Ticker: NKTR)

Who owns Nektar Therapeutics?

Is NKTR a good stock to own? Find out who bought Nektar Therapeutics, who sold Nektar Therapeutics (NKTR) stock, and who holds a large position in Nektar Therapeutics.

Fund Name Number of Shares Share Valuation As Of
OppenheimerFunds 26.00M $438.16M Dec. 31, 2015
PRIMECAP Management Company 19.78M $333.37M Dec. 31, 2015
Vanguard 10.47M $176.45M Dec. 31, 2015
BlackRock Fund Advisors 9.86M $166.10M Dec. 31, 2015
First Trust Advisors 9.60M $161.75M Dec. 31, 2015
HealthCor Management 9.20M $66.88M June 30, 2011
Ulys 5.17M $28.93M Dec. 31, 2011
JPMORGAN CHASE & CO 4.55M $50.01M March 31, 2015
Inves 4.38M $73.74M Dec. 31, 2015
BVF 4.21M $44.93M Sept. 30, 2012
Millennium Management 4.04M $44.22M Sept. 30, 2015
HealthCor Management 4.00M $46.20M June 30, 2013
Federated Investors 3.88M $65.36M Dec. 31, 2015
GRANAHAN INVESTMENT MANAGEMENT INC/MA 3.51M $54.40M Dec. 31, 2014
Camber Capital Management 3.50M $58.98M Dec. 31, 2015
STATE STREET CORPORATION 3.33M $56.09M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 3.30M $55.52M Dec. 31, 2015

Who sold Nektar Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management Dec. 31, 2010 3.49M $44.80M